Advertisement

Topics

Doyle Wealth Management Boosts Position in Teva Pharmaceutical Industries Limited

16:04 EDT 2 Aug 2017 | Topix

Doyle Wealth Management increased its position in Teva Pharmaceutical Industries Limited by 4.9% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 19,381 shares of the company's stock after buying an additional 907 shares during the period.

Original Article: Doyle Wealth Management Boosts Position in Teva Pharmaceutical Industries Limited

NEXT ARTICLE

More From BioPortfolio on "Doyle Wealth Management Boosts Position in Teva Pharmaceutical Industries Limited"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...